GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Approves Preferential Issue of Equity Shares

DIVIDEND ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 02 Jul 2026, 06:22 PM IST  ·  BSE ID: b7420cf8-7fe6-40dc-bd21-6660378dc338
View Original BSE Filing (PDF)
💡
In Simple Terms
The company is raising money by selling new shares to certain investors at a set price.
🤖 AI Summary
  • Asston Pharmaceuticals will issue 24,10,431 equity shares at Rs 115 per share.
  • The preferential issue aims to raise Rs 27,71,99,565 from non-promoter investors.
  • Shareholder approval is required for the preferential allotment.
  • An Extraordinary General Meeting is scheduled for July 31, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Equity Shares to be issued
24,10,431
Issue Price per Equity Share
₹115/-
Aggregate Issue Size
₹27,71,99,565/-
Face Value per Equity Share
₹10/-
Premium per Equity Share
₹105/-
Extraordinary General Meeting Date
July 31, 2026
🏢 How This Affects the Company
📈
Business Impact
This capital raise provides funding for the company's growth initiatives.
💰
Financial Impact
The preferential issue will increase the company's equity base and cash reserves by Rs 27,71,99,565.
⚠️
Risk Impact
The dilution of existing shareholders' equity is a factor to consider.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders, but they will vote at the EGM.
👤
Who Is Affected
All existing shareholders will experience equity dilution from the new share issuance.
🔍
Management Signal
Management is signaling an intent to raise capital to fund future growth and operations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder vote on preferential issue at EGM on July 31, 2026.
Confirmation of receipt of statutory and regulatory approvals.
Post-allotment filings detailing the completed capital raise.
MEDIUM RISK Transaction requires shareholder approval and regulatory clearances.
💡 Investor Takeaway
Asston Pharmaceuticals approved raising Rs 27,71,99,565 through preferential issue of 24,10,431 equity shares at Rs 115 each to non-promoters.
⚖️ Strengths & Concerns

✅ Positives

  • Raises capital aggregating up to Rs 27,71,99,565 for company operations and growth.
  • Issue price of Rs 115 per equity share set for preferential allotment to non-promoters.

⚠️ Concerns

  • Equity dilution for existing shareholders due to the issuance of new shares.
  • The transaction is subject to shareholder and statutory approvals, indicating potential delays.
❓ Frequently Asked Questions
What is the aggregate value of the preferential issue approved by Asston Pharmaceuticals?
The preferential issue is approved for an aggregate value of Rs 27,71,99,565/-.
What is the issue price for the new equity shares of Asston Pharmaceuticals?
The equity shares will be issued at a price of Rs 115/- per share, including a premium of Rs 105/-.
How many equity shares will Asston Pharmaceuticals issue on a preferential basis?
Asston Pharmaceuticals will issue up to 24,10,431 equity shares.
When is the Extraordinary General Meeting (EGM) scheduled for Asston Pharmaceuticals?
The EGM is scheduled to be held on Friday, July 31, 2026, at 12:30 PM.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.